BRISBANE, CA, Gate Bioscience Lands $60M Series A Financing led by Versant Ventures and a16z Bio + Health.
Gate Bioscience Lands $60M Series A Financing led by Versant Ventures and a16z Bio + Health with additional help from ARCH Venture Partners and GV.
Gate Bioscience, a biotechnology company creating a new class of medicines called Molecular Gates,unveiled the company and its scientific platform.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
